DoJ Launching “Pharmaceutical Fraud Initiative” Ahead Of Medicare Rx Implementation
This article was originally published in The Pink Sheet Daily
Executive Summary
The initiative will coordinate and increase civil and criminal enforcement resources. DoJ is also working with CMS to prevent fraud by aiding in the design and implementation of the Medicare drug benefit.